{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:36:19Z","timestamp":1787841379810,"version":"build-2784847793"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pustular psoriasis is a specialized variant of psoriasis which can be life threatening if not treated at the earliest. The pathogenesis has been recently linked to the role of interleukin 36. Apart from the corticosteroids, systemic antipsoriatics like acitretin, cyclosporine and methotrexate have been used with some success though unpredictable. With recent identification of role of IL-36 in the pathogenesis of pustular psoriasis, biologics targeting the IL-36 receptors have been used to manage the situation with high degree of success. This narrative review deals with the recent concepts of pathogenesis of pustular psoriasis as well as the current management scenario.<\/jats:p>","DOI":"10.4103\/ijd.ijd_165_24","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T13:07:45Z","timestamp":1719925665000},"page":"241-248","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Management of Pustular Psoriasis; The Way Ahead"],"prefix":"10.4103","volume":"69","author":[{"given":"Shrichand G.","family":"Parasramani","sequence":"first","affiliation":[{"name":"From the Department of DVL, Lilavati Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash R.","family":"Kar","sequence":"additional","affiliation":[{"name":"Department of DVL, IMS and SUM Hospital, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Tahiliani","sequence":"additional","affiliation":[{"name":"Department of DVL, P D Hinduja Hospital and Research Centre, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchala","family":"Parthasarathi","sequence":"additional","affiliation":[{"name":"Director, Anchala Skin Institute and Research Centre, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekhar","family":"Neema","sequence":"additional","affiliation":[{"name":"Department of DVL, AFMC, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyaki","family":"Ganguly","sequence":"additional","affiliation":[{"name":"Department of DVL, AIIMS, Raipur, Chhattisgarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharshini","family":"Sathishkumar","sequence":"additional","affiliation":[{"name":"Department of DVL, CMC, Vellore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Venkatachalam","sequence":"additional","affiliation":[{"name":"Department of DVL, RIMS, Srikakulam, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haritha","family":"Komeravelli","sequence":"additional","affiliation":[{"name":"Consultant Dermatologist, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayakar","family":"Thomas","sequence":"additional","affiliation":[{"name":"Senior Consultant Dermatologist, Apollo Hospitals and KK Child Trust Hospital, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"R1-20240829","doi-asserted-by":"crossref","first-page":"adv00034","DOI":"10.2340\/00015555-3388","article-title":"Pustular psoriasis:The dawn of a new era","volume":"100","author":"Bachelez","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"R2-20240829","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/1744666X.2019.1648209","article-title":"An update on generalized pustular psoriasis","volume":"15","author":"Gooderham","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"R3-20240829","first-page":"669","article-title":"Generalized pustular psoriasis (Zumbusch):A French epidemiological survey","volume":"16","author":"Augey","year":"2006","journal-title":"Eur J Dermatol"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2340\/00015555766871","article-title":"Generalized pustular psoriasis in Japan:Two distinct groups formed by differences in symptoms and genetic background","volume":"76","author":"Ohkawara","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N Engl J Med"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","article-title":"Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis","volume":"89","author":"Onoufriadis","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/jid.2013.230","article-title":"The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist","volume":"133","author":"Sugiura","year":"2013","journal-title":"J Invest Dermatol"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1038\/jid.2013.214","article-title":"Mutations in IL36RN in patients with generalized pustular psoriasis","volume":"133","author":"K\u00f6rber","year":"2013","journal-title":"J Invest Dermatol"},{"key":"R9-20240829","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1038\/jid.2015.288","article-title":"Activating CARD14 mutations are associated with generalized pustular psoriasis but rarely account for familial recurrence in psoriasis vulgaris","volume":"135","author":"Berki","year":"2015","journal-title":"J Invest Dermatol"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ajhg.2014.04.005","article-title":"AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking","volume":"94","author":"Setta-Kaffetzi","year":"2014","journal-title":"Am J Hum Genet"},{"key":"R11-20240829","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jid.2019.11.024","article-title":"Rare loss-of-function mutation in SERPINA3 in generalized pustular psoriasis","volume":"140","author":"Frey","year":"2020","journal-title":"J Invest Dermatol"},{"key":"R12-20240829","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ajhg.2020.06.020","article-title":"Loss-of-function myeloperoxidase mutations are associated with increased neutrophil counts and pustular skin disease","volume":"107","author":"Vergnano","year":"2020","journal-title":"Am J Hum Genet"},{"key":"R13-20240829","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaci.2016.08.056","article-title":"IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis","volume":"140","author":"Johnston","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R14-20240829","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/jdv.14386","article-title":"European consensus statement on phenotypes of pustular psoriasis","volume":"31","author":"Navarini","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R15-20240829","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/1346-8138.14523","article-title":"Japanese guidelines for the management and treatment of generalized pustular psoriasis:The new pathogenesis and treatment of GPP","volume":"45","author":"Fujita","year":"2018","journal-title":"J Dermatol"},{"key":"R16-20240829","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/ijd.12070","article-title":"Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis:Analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia","volume":"53","author":"Choon","year":"2014","journal-title":"Int J Dermatol"},{"key":"R17-20240829","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2133.1971.tb14044.x","article-title":"The prognosis of generalized pustular psoriasis","volume":"85","author":"Ryan","year":"1971","journal-title":"Br J Dermatol"},{"key":"R18-20240829","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000246631","article-title":"Pustular psoriasis and aseptic puru- lent arthritis:Possible role of leukotrienes B4 and C4 in a flare of synovitis","volume":"190","author":"Kawana","year":"1995","journal-title":"Dermatology"},{"key":"R19-20240829","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archderm.1997.03890420085010","article-title":"Pustular and erythrodermic psoriasis complicated by acute respiratory distress syndrome","volume":"133","author":"Sadeh","year":"1997","journal-title":"Arch Dermatol"},{"key":"R20-20240829","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1007\/s00403-002-0371-6","article-title":"Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity","volume":"295","author":"Umezawa","year":"2003","journal-title":"Arch Dermatol Res"},{"key":"R21-20240829","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.clindermatol.2005.10.009","article-title":"Impetigo herpetiformis","volume":"24","author":"Oumeish","year":"2006","journal-title":"Clin Dermatol"},{"key":"R22-20240829","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/IJWH.S125784","article-title":"Pustular psoriasis of pregnancy","volume":"10","author":"Trivedi","year":"2018","journal-title":"Int J Womens Health"},{"key":"R23-20240829","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/ijms17081214","article-title":"Acute generalized exanthema-touspustulosis:Pathogenesis, genetic background, clinical variants and therapy","volume":"17","author":"Feldmeyer","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R24-20240829","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/bjd.12502","article-title":"Systemic involvement of acute generalized exanthematouspustulosis:A retrospective study on 58 patients","volume":"169","author":"Hotz","year":"2013","journal-title":"Br J Dermatol"},{"key":"R25-20240829","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jaad.2015.07.017","article-title":"Acute generalized exanthematouspustulo-sis (AGEP):A review and update","volume":"73","author":"Szatkowski","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R26-20240829","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijwd.2020.02.003","article-title":"Subcornealpustular dermatosis:Comprehensive review and report of a case presenting during pregnancy","volume":"6","author":"Bhargava","year":"2020","journal-title":"Int J Womens Dermatol"},{"key":"R27-20240829","doi-asserted-by":"crossref","first-page":"e043666","DOI":"10.1136\/bmjopen-2020-043666","article-title":"Study protocol of the global Effisayil 1 phase II multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare","volume":"11","author":"Choon","year":"2021","journal-title":"BMJ Open"},{"key":"R28-20240829","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/hep.20305","article-title":"High frequency of cholestasis in generalized pustular psoriasis:Evidence for neutrophilic involvement of the biliary tract","volume":"40","author":"Viguier","year":"2004","journal-title":"Hepatology"},{"key":"R29-20240829","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1001\/2013.jamadermatol.80","article-title":"Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis","volume":"148","author":"Viguier","year":"2012","journal-title":"Arch Dermatol"},{"key":"R31-20240829","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/09546634.2017.1309349","article-title":"Retinoids:A journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects","volume":"28","author":"Khalil","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"R32-20240829","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/exd.13699","article-title":"Generalized pustular psoriasis - A model disease for specific targeted immunotherapy, systematic review","volume":"27","author":"Boehner","year":"2018","journal-title":"Exp Dermatol"},{"key":"R33-20240829","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000431171","article-title":"Dapsone therapy for pustular psoriasis:Case series and review of the literature","volume":"232","author":"Sheu","year":"2016","journal-title":"Dermatology"},{"key":"R34-20240829","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jdcr.2017.07.007","article-title":"Generalized pustular psoriasis treated with apremilast in a patient with multiple medical comorbidities","volume":"3","author":"Jeon","year":"2017","journal-title":"JAAD Case Rep"},{"issue":"Supplement_1","key":"R35-20240829","doi-asserted-by":"crossref","first-page":"i43","DOI":"10.1093\/rheumatology\/key276","article-title":"JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis","volume":"58","author":"Fragoulis","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R36-20240829","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/1744-9987.12342","article-title":"Granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis:Therapeutic outcomes in three refractory patients","volume":"19","author":"Fujisawa","year":"2015","journal-title":"Ther Apher Dial"},{"key":"R37-20240829","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijwd.2016.12.003","article-title":"Update on biologic safety for patients with psoriasis during pregnancy","volume":"3","author":"Porter","year":"2017","journal-title":"Int J Womens Dermatol"},{"key":"R38-20240829","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/annrheumdis-2017-212196","article-title":"Lack of placental transfer of certolizumab pegol during pregnancy:Results from CRIB, a prospective, postmarketing, pharmacokinetic study","volume":"77","author":"Mariette","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R39-20240829","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s13555-016-0117-6","article-title":"Systemic treatment of pediatric psoriasis:A review","volume":"6","author":"Napolitano","year":"2016","journal-title":"Dermatol Ther (Heidelb)"},{"key":"R40-20240829","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/bjd.14702","article-title":"Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma:Results from a 52-week, open-label study","volume":"176","author":"Yamasaki","year":"2017","journal-title":"Br J Dermatol"},{"key":"R41-20240829","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/jdv.12773","article-title":"Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis","volume":"29","author":"Saeki","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R42-20240829","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/1346-8138.13306","article-title":"Efficacy and safety of secukinumab in patients with generalized pustular psoriasis:A 52-week analysis from phase III open-label multicenter Japanese study","volume":"43","author":"Imafuku","year":"2016","journal-title":"J Dermatol"},{"key":"R43-20240829","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/1346-8138.14294","article-title":"Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis:Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study","volume":"45","author":"Sano","year":"2018","journal-title":"J Dermatol"},{"key":"R46-20240829","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jaad.2011.01.032","article-title":"Treatment of pustular psoriasis:From the Medical Board of the National Psoriasis Foundation","volume":"67","author":"Robinson","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R47-20240829","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.rdc.2017.04.013","article-title":"A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes","volume":"43","author":"Bandoli","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"key":"R57-20240829","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMc1811317","article-title":"Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis","volume":"380","author":"Bachelez","year":"2019","journal-title":"N Engl J Med"},{"key":"R58-20240829","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2111563","article-title":"Trial of Spesolimab for generalized psoriasis","volume":"385","author":"Bachelez","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_165_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:52:27Z","timestamp":1787838747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_165_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_165_24","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"2024-02-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}